Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the postdischarge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial.

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account